Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Natrecor in CHF: phase III results

Sep. 16, 1997

Results with PLC Systems' TMR System reported

Sep. 16, 1997

Myocardial and cerebral vasodilating effects of BMS-180448 in animals

Sep. 15, 1997

Benefits of magnesium sulfate investigated in patients with unstable angina

Sep. 15, 1997

SDZ-MRL-953 prevents sepsis in cancer patients

Sep. 15, 1997

Preclinical profile of Ono-1101 published

Sep. 15, 1997

Myocardial protective effects of Hoe-642 evaluated in porcine hearts

Sep. 12, 1997

T Cell Sciences recipient of SBIR grant to develop atherosclerosis model

Sep. 12, 1997

Promising initial results reported for VasoCare therapy in Raynaud's disease

Sep. 11, 1997

MiniMed and LRX combine forces for pulmonary hypertension treatment

Sep. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...